[Modification of the growth of the gastric mucosa by drugs]
Related Experiment Video
Updated: Oct 23, 2026

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
Published on: May 7, 2018
Abstract:
Over the last two decades it has become apparent that various drugs influence growth of gastric mucosa. For example, non-steroidal anti-inflammatory drugs increase cell shedding, which is, in rats at least, overcompensated by stimulation of cell proliferation during long-term treatment. Hyperplasia of parietal and other gastric epithelial cells has been observed in rats treated with many different ulcer drugs. Of special interest are alterations and sometimes neoplasms of gastric mucosa induced by long-term administration of very high doses of novel inhibitors of acid secretion. Some of these tumours are probably the consequence of massive hypergastrinaemia due to alkaline gastric pH and consequent lack of inhibition of gastrin release. In man the increase of gastrin is less marked even after administration of omeprazole, the most potent inhibitor of acid secretion known. Extrapolation of results from animal experiments to the situation of patients with ulcer disease is therefore questionable. However, it cannot be ruled out that total inhibition of acid secretion for a very long period could cause proliferation of gastric endocrine cells, since such tumours occur in endogenous hypergastrinaemia in patients with pernicious anaemia or Zollinger-Ellison syndrome.
More Related Videos
03:48Effects of Desmodium caudatum on Gastrointestinal Hormones and Intestinal Flora in Rats with Gastritis
Published on: March 1, 2024
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...